Market cap
$29 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
2.6
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-2.5 %
-
ROCE
-- %
-
Industry P/E
44.46
-
EV/EBITDA
-3.2
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-10.1
-
Face value
--
-
Shares outstanding
8,150,823
10 Years Aggregate
CFO
$-33.28 Mln
EBITDA
$-43.30 Mln
Net Profit
$-48.05 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Modular Medical Inc (MODD)
| -67.0 | 43.8 | -26.3 | -84.0 | -54.3 | -59.6 | -- |
|
BSE Sensex*
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
Modular Medical Inc (MODD)
| -73.4 | -24.6 | -9.0 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Modular Medical Inc (MODD)
|
3.6 | 28.9 | 0.0 | -28.0 | -- | -336.7 | -- | 2.6 |
| 64.9 | 8,484.6 | 616.9 | -75.1 | 1.7 | -9.3 | -- | 10.1 | |
| 14.6 | 9,638.1 | 6,561.1 | -578.0 | -4.5 | -10.3 | -- | 1.7 | |
| 365.1 | 9,761.6 | 2,589.3 | 222.4 | -6.0 | 3 | 44.5 | 1.3 | |
| 59.3 | 9,074.5 | 3,499.6 | -71.2 | 0.5 | -3.2 | -- | 3.8 | |
| 181.9 | 10,905.5 | 612.8 | -188.1 | -30.6 | -28.1 | -- | 16.4 | |
| 100.5 | 6,525.3 | 1,556.3 | 275.3 | 24.6 | 22.9 | 24 | 5.0 | |
| 89.5 | 5,420.5 | 1,579.2 | 145.6 | 14.3 | 8.9 | 37.2 | 3.2 | |
| 321.0 | 12,752.7 | 1,504.9 | 160.6 | 13.6 | 10.9 | 79.4 | 8.4 | |
| 182.0 | 10,222.2 | 785.1 | 41.5 | 9.9 | 2 | 251.6 | 4.8 |
Shareholding Pattern
View DetailsAbout Modular Medical Inc (MODD)
Modular Medical, Inc. operates as a medical device company. The company focuses on the design, development, and commercialization of insulin pumps. It offers Pivot product, a tubeless insulin delivery system that integrates the set into a true... tubeless patch. Modular Medical, Inc. is headquartered in San Diego, California. Read more
-
Founder, Chairman, President, CFO & Treasurer
Mr. Paul M. DiPerna
-
Founder, Chairman, President, CFO & Treasurer
Mr. Paul M. DiPerna
-
Headquarters
San Diego, CA
-
Website
FAQs for Modular Medical Inc (MODD)
What is the current share price of Modular Medical Inc (MODD) Today?
The share price of Modular Medical Inc (MODD) is $3.61 (NASDAQ) as of 27-Aug-2026 16:29 EDT. Modular Medical Inc (MODD) has given a return of -54.29% in the last 3 years.
What is the current PB & PE ratio of Modular Medical Inc (MODD)?
Since, TTM earnings of Modular Medical Inc (MODD) is negative, P/E ratio is not available.
The P/B ratio of Modular Medical Inc (MODD) is 2.63 times as on 21-Aug-2026, a 32 discount to its peers’ median range of 3.84 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
-0.87 |
1.90 |
2025 |
-0.08 |
0.09 |
2024 |
-0.11 |
0.16 |
2023 |
-0.04 |
0.10 |
2022 |
-0.07 |
0.15 |
What is the 52 Week High and Low of Modular Medical Inc (MODD)?
The 52-week high and low of Modular Medical Inc (MODD) are Rs 30.00 and Rs 1.72 as of 28-Aug-2026.
What is the market cap of Modular Medical Inc (MODD)?
Modular Medical Inc (MODD) has a market capitalisation of $ 29 Mln as on 21-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Modular Medical Inc (MODD)?
Before investing in Modular Medical Inc (MODD), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.